about
Identification of ID-1 as a potential target gene of MMSET in multiple myelomaKey role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell poolOccurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineageDifferential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177.Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency.MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation.Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils.Systems biology of neutrophil differentiation and immune response.Gene expression profiling in MDS and AML: potential and future avenues.Technical advance: immunophenotypical characterization of human neutrophil differentiation.Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation.Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow alThe transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing.Gut microbiota sustains hematopoiesis.Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucinCellular origin of prognostic chromosomal aberrations in AML patientsHemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesisModeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating CellsA conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemiaHigh-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromesA comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allograftsFlow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell graftsPluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts
P50
Q28268453-710C39BC-41E4-4B90-8B34-2AA891B09F0AQ28589730-D2E7DA69-4D9D-402B-A708-614F7019401FQ33193741-4C4253BF-E6A2-4517-8056-122711CD6316Q33366973-E1C22CD3-939F-4177-BD4D-265672EEFF46Q33753741-F0B3293A-E117-4D89-B704-33477C55E728Q34310397-1D1C62EB-B271-462A-A2D4-6D9C0AEFDD25Q34648024-66B211BC-E0BC-4206-A104-90F50972796AQ34653121-F82E1CFA-5A51-4781-833B-D19B28A9DEC4Q36339097-6C058721-79FB-4F39-BEEF-DDF6B6FDB6AFQ37858877-52B12F34-D33E-4031-80C9-940F9827EBF9Q39528748-2BA03AFD-1700-4881-902E-5139ABBA152DQ40303495-273F4454-DBD2-4D7A-8360-944914E745DFQ41845469-65C6CA4A-756B-42BC-9622-A200633176D2Q45856968-ED06C604-50AD-4CDD-839B-9774A6B315B1Q47371205-02B527F1-A311-4FE3-99C9-CCF26DFF0410Q48255550-E3DBBE2C-6BA2-4459-8912-CEB59912E407Q56601274-75F5A316-8C7B-43FA-9194-992633DE9219Q57384752-E1AAC030-E5EE-46F9-8552-C57BB30A97E4Q57384756-F1EE06D7-6C67-4B98-A3E1-8310205FF2CEQ57615422-F12AD910-0073-4A04-9361-BD3650D1A25CQ57634693-12EF17B9-4B06-4BAB-8BC2-4529281EC61FQ61783772-3C59363F-DD5B-4C99-89CC-66E72CA01A7DQ64008441-827A5577-FE9E-4DB9-A0C3-193BA22C8E61Q74630695-0B502FFE-9E02-4699-8E8C-BA83D26641EAQ77462724-F9BB64DA-673B-409E-A7A0-654B5BEFCA82Q79333295-88F43041-A721-4CB0-8DB1-1C4DD938CEE3
P50
description
researcher
@en
wetenschapper
@nl
name
K Theilgaard-Mönch
@en
K Theilgaard-Mönch
@nl
type
label
K Theilgaard-Mönch
@en
K Theilgaard-Mönch
@nl
prefLabel
K Theilgaard-Mönch
@en
K Theilgaard-Mönch
@nl
P108
P106
P31
P496
0000-0002-4239-4939